Botswana

8 Vaccines Approved for Use in Botswana

RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: xinhuanet.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: bomra.co.bw
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: xinhuanet.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
4 trials in 1 country
Approval Source: xinhuanet.com
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
14 trials in 2 countries
Approval Source: bomra.co.bw
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: bomra.co.bw
Protein Subunit

Biological E Limited

Corbevax

Approved in 2 countries
7 trials in 1 country
Approval Source: bnnbloomberg.ca

1 in Clinical Trials in Botswana

RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries